 |
Indium-111 pentetreotide |
|---|---|
| Trade Name | Neuroendomedix |
| Orphan Indication | Neuroendocrine tumors |
| USA Market Approval | USA |
| USA Designation Date | 2006-06-16 00:00:00 |
| Sponsor | RadioIsotope Therapy of America (RITA) Foundation;9701 Richmond Avenue;Houston, Texas, 77042 |
